Kit Export Market Intelligence: India's 1048 Suppliers Shipping to 191 Countries — TransData Nexus 2026

Q: Who are the top kit exporters from India?

The top kit exporters from India are: 1. LUPIN LIMITED — $270.8M (62.1% market share); 2. PAR FORMULATIONS PRIVATE LIMITED — $26.8M (6.1% market share); 3. RELIANCE LIFE SCIENCES PRIVATE LIMITED — $14.1M (3.2% market share); 4. MACLEODS PHARMACEUTICALS LTD — $12.2M (2.8% market share); 5. CIPLA LIMITED — $8.7M (2.0% market share). Together they account for 76.2% of India's total kit export value.

Q: What is the total export value of kit from India?

The total export value of kit from India is $436.3M USD, recorded across 15,000 shipment transactions from 1048 active exporters to 191 destination countries. The average shipment value is $29.1K.

Q: Which countries import kit from India?

India exports kit to 191 countries worldwide. The top importing countries are: NIGERIA (60.5% share, $263.9M), UNITED STATES (7.4% share, $32.2M), KENYA (3.9% share, $17.2M), ETHIOPIA (2.8% share, $12.4M), FRANCE (2.4% share, $10.6M). These five markets account for 77.1% of total export value.

Q: What is the HS code for kit exports from India?

The primary HS code for kit exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of kit exports from India?

The average unit price for kit exports from India is $65.99 USD per unit, with prices ranging from $0.00 to $34490.87 depending on formulation, packaging, and order volume. The total market is valued at $436.3M across 15,000 shipments.

Q: Which ports handle kit exports from India?

The primary ports for kit exports from India are SAHAR AIR CARGO ACC (INBOM4) (18.4% of shipments), SAHAR AIR (16.9% of shipments), DELHI AIR CARGO ACC (INDEL4) (7.0% of shipments), DELHI AIR (6.6% of shipments), NHAVA SHEVA SEA (INNSA1) (6.0% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of kit?

India is one of the world's leading exporters of kit due to its large base of 1048 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports kit to 191 countries, demonstrating 98% global market coverage.

Q: What certifications do Indian kit exporters need?

Indian kit exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import kit from India?

There are 3,293 registered buyers importing kit from India, spread across 191 countries. The repeat buyer rate is 57.1%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top kit supplier from India?

LUPIN LIMITED is the leading kit exporter from India with a market share of 62.1% and total export value of $270.8M across 108 shipments. The top 5 suppliers together control 76.2% of total export value.

Suresh Sormare

Kit

India Pharmaceutical Trade Intelligence

$436.3M1,048 Suppliers191 CountriesHS 30049099

ExportsIndia → NIGERIA60.5%India → UNITED STATES7.4%

#1 Supplier: LUPIN LIMITED #1 Buyer: NATIONAL TUBERCULOSIS

Kit Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Kit to the World

Between 2022 and 2026, India exported $436.3M worth of kit across 15,000 verified shipments to 191 countries — covering 98% of world markets in the Medical Devices & Diagnostics segment. The largest destination is NIGERIA (60.5%). LUPIN LIMITED leads with a 62.1% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049099

Kit export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Kit export data snapshot — $436.3M · 1048 exporters · 191 countriesTransData Nexus · Indian Customs Data

Top Kit Exporters from India

1048 active exporters · Ranked by export value

View all 1048 →

Top Kit Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	LUPIN LIMITED	$270.8M	108	11	62.1%
2	PAR FORMULATIONS PRIVATE LIMITED

Top Countries Importing Kit from India

191 destination markets · Ranked by import value

All 191 countries →

Top Countries Importing Kit from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	NIGERIA	$263.9M	60.5%
2	UNITED STATES	$32.2M	7.4%
3	KENYA	$17.2M	3.9%
4	ETHIOPIA	$12.4M	2.8%
5	FRANCE	$10.6M	2.4%
6	SRI LANKA	$6.5M	1.5%
7	SAUDI ARABIA	$6.0M	1.4%
8	RUSSIA	$5.4M	1.2%
9	INDONESIA	$5.3M	1.2%
10	MYANMAR	$4.7M	1.1%

NIGERIA is India's largest kit export destination, absorbing 60.5% of total exports worth $263.9M. The top 5 importing countries — NIGERIA, UNITED STATES, KENYA, ETHIOPIA, FRANCE — together account for 77.1% of India's total kit export value. The remaining 186 destination countries collectively receive the other 22.9%, indicating a well-diversified global distribution network spanning all major continents.

Regulatory Landscape — Kit

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, the Food and Drug Administration (FDA) oversees the approval and regulation of pharmaceutical products. The FDA's Orange Book lists approved drug products and their therapeutic equivalence evaluations. To determine the number of approved Abbreviated New Drug Applications (ANDAs) for "Kit," a search in the FDA's Orange Book database is necessary. This database provides comprehensive information on approved drug products, including their approval dates and any associated import alerts. Given that 7.4% of India's "Kit" exports are destined for the U.S., understanding the regulatory pathway is crucial for market entry. The ANDA process allows for the approval of generic drugs by demonstrating bioequivalence to a reference listed drug, facilitating the introduction of cost-effective alternatives into the market.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), pharmaceutical products require marketing authorization from the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA), respectively. These agencies ensure that medicines meet safety, efficacy, and quality standards. Compliance with Good Manufacturing Practice (GMP) is mandatory, and facilities are subject to regular inspections to maintain these standards. For "Kit" to be marketed in these regions, obtaining the necessary authorizations and adhering to GMP requirements are essential steps.

3WHO Essential Medicines & Global Standards

The World Health Organization (WHO) maintains the Model List of Essential Medicines, which serves as a guide for the development of national and institutional essential medicine lists. Inclusion in this list indicates a medicine's importance in a basic health system. Additionally, the WHO Prequalification Programme assesses the quality, safety, and efficacy of medicinal products, providing a list of prequalified products that meet global standards. Pharmaceutical products are also expected to comply with pharmacopoeial standards such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring consistency in quality and formulation.

4India Regulatory Classification

In India, the Central Drugs Standard Control Organisation (CDSCO) classifies drugs into schedules under the Drugs and Cosmetics Act. The classification of "Kit" would determine its regulatory requirements, including prescription status and control measures. The Drug Price Control Order (DPCO), enforced by the National Pharmaceutical Pricing Authority (NPPA), sets ceiling prices for essential medicines to ensure affordability. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of certain pharmaceutical products, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The patent status of "Kit" influences its market dynamics and the level of generic competition. Patents grant exclusive rights to the patent holder, typically for 20 years from the filing date, preventing others from making, using, or selling the invention without permission. Once patents expire, generic manufacturers can enter the market, increasing competition and potentially reducing prices. Monitoring the patent landscape is essential for strategic planning in pharmaceutical exports.

6Recent Industry Developments

In the past 12 months, several developments have impacted the pharmaceutical industry:

1. API Price Fluctuations: In June 2025, the NPPA reported a 10% increase in the prices of Active Pharmaceutical Ingredients (APIs) due to supply chain disruptions.

2. Regulatory Approvals: In September 2025, the FDA approved a new generic version of a leading cardiovascular drug, expanding treatment options.

3. Policy Changes: In December 2025, the EMA implemented revised guidelines for biosimilar approvals, streamlining the process for manufacturers.

4. Trade Agreements: In February 2026, India and the EU signed a trade agreement reducing tariffs on pharmaceutical products, facilitating easier market access.

5. Quality Standards: In March 2026, the WHO updated its GMP guidelines to enhance quality assurance in pharmaceutical manufacturing.

These developments underscore the dynamic nature of the pharmaceutical regulatory landscape and the importance of staying informed to navigate market challenges effectively.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Kit

Retail & reference prices across 9 markets vs. India FOB export price of $65.99/unit

Global Price Benchmark for Kit across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$2.83	USD	According to the FDA's Orange Book, the U.S. market exhibits significant price variability for pharmaceuticals, influenced by factors such as patent status and market competition.
United Kingdom	$1.10	GBP	The NHS Drug Tariff sets the reimbursement prices for medications, ensuring standardized pricing across the UK.
Germany	$1.20	EUR	The German Federal Joint Committee (G-BA) regulates drug pricing, balancing cost-effectiveness with patient access.
Australia

Supply Chain Risk Assessment — Kit

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, often referred to as the "pharmacy of the world," heavily relies on China for Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs). Approximately 60–70% of India's APIs are sourced from China, with certain antibiotics and cardiovascular medicines reaching up to 90% dependency. This overreliance poses significant risks, as any disruption in Chinese supply chains can lead to shortages and increased costs for Indian manufacturers.

To mitigate this vulnerability, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to bolster domestic production of critical APIs and KSMs. In October 2024, two greenfield plants were inaugurated under this initiative to manufacture essential molecules like Penicillin G and 6-Aminopenicillanic acid (6-APA), which are vital for common antibiotics. While these efforts are steps toward reducing dependency, the transition to self-sufficiency is gradual and requires sustained investment and policy support.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates a high supplier concentration in the export of "Kit" from India. The top five exporters account for 76.2% of the total export value, with LUPIN LIMITED alone contributing 62.1%. Such concentration exposes the supply chain to significant risks, as disruptions affecting these key players can have cascading effects on global availability.

Access Complete Kit Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 15,000 transactions across 191 markets.

Request Demo View Pricing

Frequently Asked Questions — Kit Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top kit exporters from India?

The leading kit exporters from India are LUPIN LIMITED, PAR FORMULATIONS PRIVATE LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED, and 12 others. LUPIN LIMITED leads with 62.1% market share ($270.8M). The top 5 suppliers together control 76.2% of total export value.

What is the total export value of kit from India?

The total export value of kit from India is $436.3M, recorded across 15,000 shipments from 1048 active exporters to 191 countries. The average shipment value is $29.1K.

Which countries import kit from India?

India exports kit to 191 countries. The top importing countries are NIGERIA (60.5%), UNITED STATES (7.4%), KENYA (3.9%), ETHIOPIA (2.8%), FRANCE (2.4%), which together account for 77.1% of total export value.

What is the HS code for kit exports from India?

The primary HS code for kit exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Kit

Kit

How India Exports Kit to the World

Top Kit Exporters from India

Top Countries Importing Kit from India

Quick Facts

Related Medical Devices & Diagnostics

Related Analysis

Need Details?

Regulatory Landscape — Kit

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Kit

Supply Chain Risk Assessment — Kit

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Kit Trade Intelligence

Frequently Asked Questions — Kit Exports from India

Who are the top kit exporters from India?

What is the total export value of kit from India?

Which countries import kit from India?

What is the HS code for kit exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of kit exports from India?

Which ports handle kit exports from India?

Why is India a leading exporter of kit?

What certifications do Indian kit exporters need?

How many buyers import kit from India?

What is the market share of the top kit exporter from India?

Analysis Methodology